Low-Dose Recombinant Human Erythropoietin Therapy in Chronic Hemodialysis Patients
- 1 July 1991
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 18 (1), 60-64
- https://doi.org/10.1016/s0272-6386(12)80291-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Analysis of Initial Resistance of Erythropoiesis to Treatment with Recombinant Human ErythropoietinPublished by S. Karger AG ,2015
- Dose-Related Effects of Recombinant Human Erythropoietin on ErythropoiesisPublished by S. Karger AG ,2015
- Recombinant Human Erythropoietin: 18 Months' Experience in Hemodialysis PatientsAmerican Journal of Kidney Diseases, 1990
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Iron status in patients receiving erythropoietin for dialysis-associated anemiaKidney International, 1989
- Blood Rheology and Hypertension in Hemodialysis Patients Treated with ErythropoietinAmerican Journal of Nephrology, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Hemodynamics of Uremic AnemiaCirculation, 1971